1. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008; 118(4): 1311-21. doi: 10.1172/JCI34261. PMid:18382743 PMCid:PMC2276811

2. Del Brutto OH. Human Neurocysticercosis: An Overview. Pathogens. 2022;11:1212. doi: 10.3390/pathogens11101212. PMid:36297269 PMCid:PMC9607454

3. Badwaik N, Gharde P, Shinde RK, Tayade HT, Navandhar PS, Patil M. Hydatid Cyst or Echinococcosis: A Comprehensive Review of Transmission, Clinical Manifestations, Diagnosis, and Multidisciplinary Treatment. Cureus. 2024; 16(7): e63713. doi: 10.7759/cureus.63713.

4. Lo NC, Bezerra FSM, Colley DG, Fleming FM, Homeida M, Kabatereine N, et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. Lancet Infect Dis. 2022; 22(11):e327-35. doi: 10.1016/S1473-3099(22)00221-3. PMid:35594896

5. Tanabe MB, Caravedo MA, White AC Jr, Cabada MM. An Update on the Pathogenesis of Fascioliasis: What Do We Know? Res Rep Trop Med. 2024; 15: 13-24. doi: 10.2147/RRTM.S397138. PMid:38371362 PMCid:PMC10874186

6. Saelens G, Gabriël S. Currently Available Monitoring and Surveillance Systems for Taenia spp., Echinococcus spp., Schistosoma spp., and Soil-Transmitted Helminths at the Control/Elimination Stage: A Systematic Review. Pathogens. 2020; 9(1):47. doi: 10.3390/pathogens9010047. PMid:31935916 PMCid:PMC7168685

7. Hong ST. Albendazole and Praziquantel: Review and Safety Monitoring in Korea. Infect Chemother. 2018; 50(1):1-10. doi: 10.3947/ic.2018.50.1.1. PMid:29637747 PMCid:PMC5895825

8. Nixon SA, Welz C, Woods DJ, Costa-Junior L, Zamanian M, Martin RJ. Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics. Int J Parasitol Drugs Drug Resist. 2020;14:8-16. doi: 10.1016/j.ijpddr.2020.07.001. PMid:32814269 PMCid:PMC7452592

9. Hamamoto Filho PT, Rodríguez-Rivas R, Fleury A. Neurocysticercosis: A Review into Treatment Options, Indications, and Their Efficacy. Res Rep Trop Med. 2022;13:67-79. doi: 10.2147/RRTM.S375650. PMid:36601353 PMCid:PMC9807125

10. Crellen T, Walker M, Lamberton PL, Kabatereine NB, Tukahebwa EM, Cotton JA, et al. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration. Clin Infect Dis. 2016;63(9):1151-9. doi: 10.1093/cid/ciw506. PMid:27470241 PMCid:PMC5064161

11. Tiwari R, Gupta RP, Singh VK, Kumar A, Madhukar P, Sundar S, et al. Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment. ACS Omega. 2023;8(45):42014-27. doi: 10.1021/acsomega.3c04587. PMid:38024747 PMCid:PMC10655914

12. Qadeer A, Ullah H, Sohail M, Safi SZ, Rahim A, Saleh TA. Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis. Front Bioeng Biotechnol. 2022; 10: 1013354. doi:10.3389/fbioe.2022.1013354. PMid:36568300 PMCid:PMC9780462

13. Yagublu V, Karimova A, Hajibabazadeh J, Reissfelder C, Muradov M, Bellucci S, et al. Overview of Physicochemical Properties of Nanoparticles as Drug Carriers for Targeted Cancer Therapy. J Funct Biomater. 2022;13(4):196. doi: 10.3390/jfb13040196. PMid:36278665 PMCid:PMC9590029

14. Benelli G. Gold nanoparticles - against parasites and insect vectors. Acta Trop. 2018;178:73-80. doi: 10.1016/j.actatropica.2017.10.021. PMid:29092797

15. Heshmati F, Sangar SG, Amoozadehsamakoosh A, Azadi E, Komeili N. The Role of Metallic Nanoparticles in the Prevention and Treatment of Parasitic Diseases in Poultry. J World's Poult Sci. 2023;2(3):13-9. doi: 10.58803/jwps.v2i3.15.

16. Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H. Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected Mice. Pathogens. 2025;14(3):240. doi: 10.3390/pathogens14030240. PMid:40137725 PMCid:PMC11944628

17. Sun Y, Chen D, Pan Y, Qu W, Hao H, Wang X, et al. Nanoparticles for antiparasitic drug delivery. Drug Deliv. 2019;26(1):1206-21. doi: 10.1080/10717544.2019.1692968.PMid:31746243 PMCid:PMC6882479

18. Farhadi M, Haniloo A, Rostamizadeh K, Ahmadi N. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis. Parasitol Res. 2021;120(12):4049-60. doi: 10.1007/s00436-021-07343-0. PMid:34669034

19. Pensel PE, Gamboa GU, Fabbri J, Ceballos L, Bruni SS, Alvarez LI, et al. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop. 2015; 152:185-94. doi: 10.1016/j.actatropica.2015.09.016.PMid:26409727

20. Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic Nanoparticles and Their Targeted Delivery Applications. Molecules. 2020;25(9):2193. doi: 10.3390/molecules25092193. PMid:32397080 PMCid:PMC7248934

21. Ciftci F, Özarslan AC, Kantarci IC, Yelkenci A, Tavukcuoglu O, Ghorbanpour M. Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment. Molecules. 2020;25(9):2193. doi: 10.3390/molecules25092193. PMid:32397080 PMCid:PMC7248934

22. Ng'etich AI, Amoah ID, Bux F, Kumari S. Anthelmintic resistance in soil-transmitted helminths: One-Health considerations. Parasitol Res. 2023;123(1):62. doi: 10.1007/s00436-023-08088-8. PMid:38114766 PMCid:PMC10730643

23. Qi SS, Sun JH, Yu HH, Yu SQ. Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy. Drug Deliv. 2017; 24(1):1909-26. doi: 10.1080/10717544.2017.1410256. PMid:29191057 PMCid:PMC8241150

24. Khalifa HO, Oreiby A, Mohammed T, Abdelhamid MAA, Sholkamy EN, Hashem H, et al. Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria. Front Cell Infect Microbiol. 2025;15:1599113. doi: 10.3389/fcimb.2025.1599113. PMid:40895297 PMCid:PMC12390974